You are using an outdated browser. Please upgrade your browser to improve your experience.
IBM Micromedex NeoFax Ref

IBM Micromedex® NeoFax is available free to online subscribers of Micromedex Standard NeoFax

IBM Micromedex® NeoFax is available free to online subscribers of Micromedex Standard NeoFax

IBM Micromedex NeoFax Ref

by Truven Health Analytics Inc.
IBM Micromedex NeoFax Ref
IBM Micromedex NeoFax Ref
IBM Micromedex NeoFax Ref

What is it about?

IBM Micromedex® NeoFax is available free to online subscribers of Micromedex Standard NeoFax.

IBM Micromedex NeoFax Ref

App Details

Version
1.28.1
Rating
NA
Size
7Mb
Genre
Medicina Referencia
Last updated
December 19, 2018
Release date
July 26, 2013
More info

App Screenshots

IBM Micromedex NeoFax Ref screenshot-0
IBM Micromedex NeoFax Ref screenshot-1
IBM Micromedex NeoFax Ref screenshot-2
IBM Micromedex NeoFax Ref screenshot-3
IBM Micromedex NeoFax Ref screenshot-4

App Store Description

IBM Micromedex® NeoFax is available free to online subscribers of Micromedex Standard NeoFax.

IBM Micromedex NeoFax is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.

IBM Micromedex® is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Micromedex for almost 40 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.

IBM Micromedex NeoFax drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).

Do you work at a facility that subscribes to IBM Micromedex® NeoFax®? Check with your Head of Pediatrics, Director of Pediatrics, Director of the NICU, Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.

If you work at a facility that subscribes to IBM Micromedex® NeoFax® you may obtain free access to this app with your IBM Micromedex NeoFax password. Contact support at https://www-01.ibm.com/software/support/watsonhealth/truven_support.html.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.